Remdezivir, one of the drugs that Donald Trump took when he developed Covid-19, should not be used in hospitals because there is no evidence that it works, advises the World Health Organization.
The American president was an enthusiastic supporter of the drug to the point where in July he boasted that he had bought the entire stock of the world for Americans. However, the WHO Guidelines Committee said that patients with Covid could be better off without it.
The WHO has issued what he calls “living guidelines”
There are other problems with remdezivir. Manufactured by the American company Gilead, it is extremely expensive and must be given intravenously. The guidelines, published in the British Medical Journal, conclude that “most patients would not prefer intravenous treatment with remdezivir given the low safety. Any beneficial effects of remdezivir, if any, are likely to be small and the possibility of significant harm remains. “